1 Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64:97–108.
2 Nougaret S, Brunel H, Bourbotte G, Bonafé A. Imagerie de diffusion et maladie de Creutzfeldt-Jakob sporadique. Journal of Neuroradiology. 2017;34(4):260–6.
3 Kamtchum TJ, Vargas MI, Burkhardt K, Chofflon M. Illustrating the relevance of updated diagnostic criteria for sporadic Creutzfeldt-Jakob disease: a teaching neurocase. BMJ Case Reports. 2013;2013:bcr2013010061.
4 Hyeon JW, Kim SY, Lee J, Park JS, Hwang KJ, Lee SM, et al. Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratory». Scientific Reports.2015;5(15283):1–9.
5 Kovacs GG, Rahimi J, Ströbel T, Lutz MI, Regelsberger G, Streichenberger N, et al. Tau Pathology in Creutzfeldt-Jakob Disease Revisited. Brain Pathology.2017;27(3):332–44.
6 Grangeon L, Paquet C, Bombois S, Maltete D, Hannequin D, David Wallon. Démence et protéine Tau élevée: quels diagnostics craindre? Revue Neurologique. 2016;172:A8–9.
7 Diagnostic Criteria | Creutzfeldt-Jakob Disease, Classic (CJD) | Prion Disease | CDC, 25 janvier 2019. Available from: https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
8 Brandel JP, Laplanche JL, Salomon D, Beaudry P, Haik S, et Peoc’h K. «E – 4 Sensibilité de la détection la protéine 14-3-3 pour le diagnostic de la maladie de Creutzfeldt-Jakob sporadique: données de 1997 à 2006». Revue Neurologique. 2007;163(4):168.
9 Behaeghe O, Mangelschots E, De Vil B, et Cras P. A Systematic Review Comparing the Diagnostic Value of 14-3-3 Protein in the Cerebrospinal Fluid, RT-QuIC and RT-QuIC on Nasal Brushing in Sporadic Creutzfeldt–Jakob Disease. Acta Neurologica Belgica. 2018;118(3):395–403.
10 Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335(13):924–30.
11 Bongianni M, Orrù C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G et al. Diagnosis of Human Prion Disease Using Real-Time QuakingInduced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples. JAMA Neurology. 2017;74(2):155–162.
12 Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, et al. High Diagnostic Value of Second Generation CSF RT-QuIC across the Wide Spectrum of CJD Prions. Scientific Reports.2017;7(10655):1–8.
13 Green AJE. RT-QuIC: A New Test for Sporadic CJD. Practical Neurology. 2019;19(1):49–55.
14 Atarashi R, Satoh K, Sano K, Fuse T, Yamanaka H, Yamaguchi N, et al. PPo8-28: Ultrasensitive Human Prion Detection in Cerebrospinal Fluids by Real-time Quaking-Induced Conversion». Prion.2010;4(3):204–21.
15 OFSP, Office fédéral de la santé publique. «Chiffres Maladies infectieuses», 26.03.2021. Available from: https://www.bag.admin.ch/bag/fr/home/zahlen-und-statistiken/zahlen-zu-infektionskrankheiten.exturl.html/aHR0cHM6Ly9tZWxkZXN5c3RlbWUuYmFnYXBwcy5jaC9pbmZyZX/BvcnRpbmcvZGF0ZW5kZXRhaWxzL2YvY2pkLmh0bWw_d2ViZ3Jh/Yj1pZ25vcmU=.html